SCHEMBL29633671

SCHEMBL29633671

COc1ccc(C[C@@H](C(=O)OC(C)(C)C)N(C)C(=O)OCC2c3ccccc3-c3ccccc32)c(F)c1

nearest known ligand 0.36

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
FABP5 Q01469 1/20 0.34
PRKCZ Q05513 1/20 0.33
P2RX7 Q99572 1/20 0.33
BMP1 P13497 1/20 0.33
MDM2 Q00987 3/20 0.33
PIK3CG P48736 1/20 0.32
EPHX2 P34913 1/20 0.32
MDM4 O15151 1/20 0.32
TP53 P04637 1/20 0.32
KMT2A Q03164 1/20 0.31
MMP13 P45452 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29633781 1.00 FABP5 (0.34) FABP5PRKCZP2RX7BMP1MDM2
SCHEMBL22454853 1.00 FABP5 (0.34) FABP5PRKCZP2RX7BMP1MDM2
SCHEMBL29633996 0.92 FABP5 (0.34) FABP5PRKCZP2RX7BMP1MDM2
SCHEMBL29633876 0.89 FABP5 (0.38) FABP5P2RX7BMP1MDM2EPHX2
SCHEMBL29633918 0.88 CTSS (0.38) FABP5EPHX2KMT2A
SCHEMBL29633889 0.88 SLC6A4 (0.34) MDM2EPHX2KMT2A
SCHEMBL22454717 0.88 SLC6A4 (0.34) MDM2EPHX2KMT2A
SCHEMBL29633730 0.88 SLC6A4 (0.34) MDM2EPHX2KMT2A
SCHEMBL29633748 0.85 FABP5 (0.37) FABP5BMP1MDM2
SCHEMBL29633843 0.85 CACNA1B (0.36) FABP5EPHX2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240376044-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE CHUGAI PHARMACEUTICAL CO LTD (JP) 2024-11-14 US disclosed
US-12071396-B2 Method for preparing aromatic amino acid derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2024-08-27 US disclosed
US-20220144762-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2022-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240376044-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE DDC, AADAT, TYR FABP5 608/4885PRKCZ 3657/4885P2RX7 4209/4885
US-20220144762-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE DDC, AADAT, TYR FABP5 608/4885PRKCZ 3657/4885P2RX7 4209/4885
US-12071396-B2 Method for preparing aromatic amino acid derivative DDC, AADAT, TYR FABP5 608/4885PRKCZ 3657/4885P2RX7 4209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.